Delivery Order SPE2DB22D3301-SPE2DB24FZ4SF
Award Date
9/20/24
Potential Completion Date
9/23/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,136.62. It is for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a medical product. The contract has an ultimate completion date of May 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,711.35, is a delivery order for the supply of GADAVIST 1 MMOL/ML BULK VIAL 30ML, a pharmaceutical product. The contract has an ultimate completion date of July 29, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is a delivery order worth $1,711.35 for the supply of Gadavist 1 mmol/mL bulk vials. The contract has an ultimate completion date of September 10, 2024 and is a firm fixed-price contract. AmerisourceBergen has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies for a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.20 firm fixed-price delivery order is for the supply of GADAVIST 10 MMOL/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order worth $1,417.60 for the procurement of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 9, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of GADAVIST 1 MMOL/ML BULK VIAL 30ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,711.35 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of July 2, 2024 and was awarded on July 1, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,274.88, for the supply of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. The contract has an Ultimate Completion Date of April 1, 2025 and was awarded on March 31, 2025. This award is not a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.79 firm fixed-price delivery order is for the supply of 4565188888 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has an ultimate completion date of July 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of Gadavist 1 mmol/ml bulk vial 30ml. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,711.35. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. The contract was not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Gadavist, a medical contrast agent, in 30 ml vials. The award, valued at $1,140.90, is a firm fixed-price delivery order contract with a completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...